0527-4956 NDC - LEVOTHYROXINE SODIUM ()

Drug Information

  • Product NDC: 0527-4956
  • Proprietary Name: Levothyroxine Sodium
  • Non Proprietary Name:
  • Active Ingredient(s):
  • Administration Route(s):
  • Dosage Form(s):

Labeler Information

Field Name Field Value
Labeler Name: Lannett Company, Inc.
Product Type:
FDA Application Number: NDA021924
Marketing Category: NDA AUTHORIZED GENERIC
Start Marketing Date:11/2/2020
End Marketing Date:10/31/2025

Package Information

No. Package Code Package Description Billing Unit
10527-4956-323 BLISTER PACK in 1 CARTON (0527-4956-32) / 10 CAPSULE in 1 BLISTER PACK

NDC Record

Field Name Field Value Definition
PRODUCT NDC0527-4956The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMELevothyroxine SodiumIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
START MARKETING DATE11/2/2020The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
END MARKETING DATE10/31/2025The translation of the dosage form Code submitted by the firm.
MARKETING CATEGORY NAMENDA AUTHORIZED GENERICThe translation of the route code submitted by the firm, indicating route of administration.
APPLICATION NUMBERNDA021924This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMELannett Company, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025